Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Abstract Background Cholangiocarcinoma (CCA) may arise in the intra- or extrahepatic biliary tract and is associated with a poor prognosis. Despite recent advances, to date there is still no established targeted therapeutic approach available. Non-surgical therapeutic agents are urgently needed, as...

Full description

Bibliographic Details
Main Authors: Mark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, Marcus Renner, Rémi Longuespée, Thomas Albrecht, Moritz Loeffler, Stephan Singer, Arianeb Mehrabi, Monika Nadja Vogel, Anita Pathil, Bruno Köhler, Christoph Springfeld, Christian Rupp, Karl Heinz Weiss, Benjamin Goeppert
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
PD-L1
Cholangiocarcinoma
CD274
28–8
SP142
SP263
Online Access:http://link.springer.com/article/10.1186/s12885-018-5254-0

Internet

http://link.springer.com/article/10.1186/s12885-018-5254-0

Similar Items